Note 6 - Subsequent Events

On April 28, 2026, the Company closed a registered direct offering, a concurrent private placement, and an insider-led private placement, issuing in the aggregate 1,114,984 shares of common stock, pre-funded warrants to purchase 696,866 shares (exercise price $0.001), and Series A-1 and Series A-2 common warrants to purchase up to 1,811,850 shares each at an exercise price of $1.435 per share. Aggregate gross proceeds were approximately $2.6 million, of which approximately $0.6 million was invested by certain officers and directors of the Company, including the Chairman and Chief Executive Officer and another member of the Board of Directors, at a per-share price equal to that of the registered direct offering, with one-for-one Series A-1 and Series A-2 warrant coverage. The common warrants become exercisable upon stockholder approval; the Series A-1 warrants expire five years, and the Series A-2 warrants expire eighteen months, after the later of stockholder approval and the effective date of the related resale registration statement. The placement agent received a 7.0% cash fee, 1.0% management fee, expense reimbursement, and warrants to purchase 97,561 shares at $1.7938 per share. The Company intends to use the net proceeds for working capital and general corporate purposes.